Publication date: Dec 04, 2024
Background: The COVID-19 pandemic markedly increased the number of patients with infection-related acute respiratory distress syndrome who required extracorporeal membrane oxygenation (ECMO) and multiple blood transfusions. This study aimed to assess a potential correlation between the daily rate of transfused blood products and the intensive care unit (ICU) outcome of ECMO-supported COVID-19 patients. Methods: Data were retrieved from the electronic databases of three Israeli tertiary care centers. All COVID-19 patients treated with ECMO for >3 days in these centers between July 2020 and November 2021 were included in the analysis. Results: The study incorporated 106 patients [median age 49 (17-73) years]. The median numbers of ECMO days and daily transfused packed red blood cell (PRBC) units were 20. 5 (4-240) and 0. 61 (0-2. 82), respectively. In multivariate analysis, age ≥50 years was an independent factor for ICU mortality [odds ratio (OR) 4. 47). In ECMO-supported patients for
Open Access PDF
| Concepts | Keywords |
|---|---|
| Daily | COVID-19 |
| July | extracorporeal membrane oxygenation |
| November | |
| Pandemic | |
| Transfusion |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | IDO | blood |
| disease | MESH | infection |
| disease | MESH | acute respiratory distress syndrome |
| disease | IDO | cell |
| drug | DRUGBANK | Coenzyme M |